Cargando…

Nuclear morphometric features in benign breast tissue and risk of subsequent breast cancer

Certain nuclear morphometric features measured in breast tumor tissue have been shown to predict the prognosis of breast cancer patients. However, the application of these features to predicting risk of breast cancer development has received little attention. We conducted a case-control study to eva...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Yan, Koop, Esther A., van Diest, Paul J., Kandel, Rita A., Rohan, Thomas E.
Formato: Texto
Lenguaje:English
Publicado: Kluwer Academic Publishers-Plenum Publishers 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2092407/
https://www.ncbi.nlm.nih.gov/pubmed/17061043
http://dx.doi.org/10.1007/s10549-006-9396-4
_version_ 1782138194877218816
author Cui, Yan
Koop, Esther A.
van Diest, Paul J.
Kandel, Rita A.
Rohan, Thomas E.
author_facet Cui, Yan
Koop, Esther A.
van Diest, Paul J.
Kandel, Rita A.
Rohan, Thomas E.
author_sort Cui, Yan
collection PubMed
description Certain nuclear morphometric features measured in breast tumor tissue have been shown to predict the prognosis of breast cancer patients. However, the application of these features to predicting risk of breast cancer development has received little attention. We conducted a case-control study to evaluate nuclear morphometric features in benign breast tissue in association with subsequent breast cancer risk. The study was nested within a cohort of 4,888 women with a histopathologic diagnosis of benign breast disease (BBD) and involved 61 cases and 71 controls, amongst whom there were 53 matched case-control sets. Conditional logistic regression models were fitted to assess various measurements of nuclear size and nuclear shape factors in relation to subsequent breast cancer risk. In multivariate analysis, subsequent breast cancer risk was positively associated with a nuclear shape factor that takes the shortest nuclear axis and the longest nuclear axis into consideration simultaneously (highest quartile versus lowest 3 quartiles: odds ratio = 3.07, 95% confidence limits = 1.61, 5.84). In contrast, there was no alteration in subsequent breast cancer risk in association with nuclear size features and other shape factors. In conclusion, our study results suggest that the shape factor that takes both the shortest nuclear axis and the longest nuclear axis into consideration might be of value to predict subsequent development of breast cancer among women with BBD.
format Text
id pubmed-2092407
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Kluwer Academic Publishers-Plenum Publishers
record_format MEDLINE/PubMed
spelling pubmed-20924072007-11-28 Nuclear morphometric features in benign breast tissue and risk of subsequent breast cancer Cui, Yan Koop, Esther A. van Diest, Paul J. Kandel, Rita A. Rohan, Thomas E. Breast Cancer Res Treat Original Paper Certain nuclear morphometric features measured in breast tumor tissue have been shown to predict the prognosis of breast cancer patients. However, the application of these features to predicting risk of breast cancer development has received little attention. We conducted a case-control study to evaluate nuclear morphometric features in benign breast tissue in association with subsequent breast cancer risk. The study was nested within a cohort of 4,888 women with a histopathologic diagnosis of benign breast disease (BBD) and involved 61 cases and 71 controls, amongst whom there were 53 matched case-control sets. Conditional logistic regression models were fitted to assess various measurements of nuclear size and nuclear shape factors in relation to subsequent breast cancer risk. In multivariate analysis, subsequent breast cancer risk was positively associated with a nuclear shape factor that takes the shortest nuclear axis and the longest nuclear axis into consideration simultaneously (highest quartile versus lowest 3 quartiles: odds ratio = 3.07, 95% confidence limits = 1.61, 5.84). In contrast, there was no alteration in subsequent breast cancer risk in association with nuclear size features and other shape factors. In conclusion, our study results suggest that the shape factor that takes both the shortest nuclear axis and the longest nuclear axis into consideration might be of value to predict subsequent development of breast cancer among women with BBD. Kluwer Academic Publishers-Plenum Publishers 2006-10-24 2007-07 /pmc/articles/PMC2092407/ /pubmed/17061043 http://dx.doi.org/10.1007/s10549-006-9396-4 Text en © Springer Science+Business Media, LLC 2006
spellingShingle Original Paper
Cui, Yan
Koop, Esther A.
van Diest, Paul J.
Kandel, Rita A.
Rohan, Thomas E.
Nuclear morphometric features in benign breast tissue and risk of subsequent breast cancer
title Nuclear morphometric features in benign breast tissue and risk of subsequent breast cancer
title_full Nuclear morphometric features in benign breast tissue and risk of subsequent breast cancer
title_fullStr Nuclear morphometric features in benign breast tissue and risk of subsequent breast cancer
title_full_unstemmed Nuclear morphometric features in benign breast tissue and risk of subsequent breast cancer
title_short Nuclear morphometric features in benign breast tissue and risk of subsequent breast cancer
title_sort nuclear morphometric features in benign breast tissue and risk of subsequent breast cancer
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2092407/
https://www.ncbi.nlm.nih.gov/pubmed/17061043
http://dx.doi.org/10.1007/s10549-006-9396-4
work_keys_str_mv AT cuiyan nuclearmorphometricfeaturesinbenignbreasttissueandriskofsubsequentbreastcancer
AT koopesthera nuclearmorphometricfeaturesinbenignbreasttissueandriskofsubsequentbreastcancer
AT vandiestpaulj nuclearmorphometricfeaturesinbenignbreasttissueandriskofsubsequentbreastcancer
AT kandelritaa nuclearmorphometricfeaturesinbenignbreasttissueandriskofsubsequentbreastcancer
AT rohanthomase nuclearmorphometricfeaturesinbenignbreasttissueandriskofsubsequentbreastcancer